highperformr logo

Robert Bartholomew

President and CEO, Dewpoint
Milford, Michigan,United States
Find Robert Bartholomew's Email
Find Robert Bartholomew’s Phone

Robert Bartholomew's Overview

Total Experience23 years
CompanyDewpoint
CountryUnited States

Robert Bartholomew is an American-born sociologist, author, and academic, currently an Honorary Senior Lecturer in the Department of Psychological Medicine at the University of Auckland, New Zealand. He is renowned for his extensive research and publications on mass hysteria, social delusions, moral panics, and unusual socio-cultural phenomena. Bartholomew has authored numerous influential books and articles, contributing significantly to the fields of sociology and psychology. He is known for his critical examination of extraordinary claims and popular beliefs, often providing scientific and historical context to seemingly inexplicable events. His work frequently appears in both academic journals and popular media, making complex topics accessible to a wider audience.

Professional Summary

Robert Bartholomew's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Dewpoint - President and CEO (2020 to Present)
HP Enterprises Services - Director, Eastern United States (2014 to 2015)
HP Enterprise Services - Senior Account Executive (2010 to 2013)
EDS - Senior Account Executive (2007 to 2010)

Notable Achievements

Prolific Author on Mass Hysteria and Social Delusions

Authored and co-authored over 15 influential books, including 'Hoaxes, Myths, and Manias: Why We Need Critical Thinking' and 'Outbreak! The Encyclopedia of Extraordinary Social Behavior,' establishing him as a leading voice in the study of collective behavior and fringe beliefs.

Expert in Medical Sociology and Mass Psychogenic Illness

Recognized as a leading expert on mass psychogenic illness (MPI) and controversial health scares, often called upon by media and academic institutions for his insights into phenomena like Havana Syndrome and Morgellons disease.

Contributions to Academic Journals and Mainstream Media

Published extensively in peer-reviewed academic journals and has written for prominent media outlets like The Guardian, Skeptical Inquirer, and Psychology Today, bridging the gap between academic research and public understanding.

International Academic Career

Held academic teaching and research positions in several countries, including the United States, Australia, and Malaysia, before his current role in New Zealand, showcasing a global perspective in his work.

Educational Background

Bachelor's degree, Computer Science

Ferris State University - Year 1983

Bachelor's degree, Computer and Information Sciences and Support Services

Ferris State University - Year 1983

Buying Intent Signals for Robert Bartholomew

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Dewpoint
Total employees180
HeadquartersBoston
Founded2018

Dewpoint Therapeutics is a biotechnology company focused on the discovery and development of drugs that target biomolecular condensates. These condensates are membrane-less organelles that play crucial roles in cellular organization and function. By understanding and modulating condensate biology, Dewpoint aims to develop novel treatments for a wide range of complex diseases, including neurodegenerative disorders, cancer, and viral infections. Their approach combines cutting-edge biology with proprietary technology platforms to pioneer this new area of medicine.

Dewpoint Funding Information
$399.7M - Total Funding Raised
$150M - Most recent funding amount
4 - Number of funding rounds
July 12, 2022 - Latest funding round
Lead Investors:
ARCH Venture Partners
SoftBank Vision Fund 2
Polaris Partners
Samsara BioCapital
EcoR1 Capital
SR One
Leaps by Bayer
Catalio Capital Management
Henri Termeer Transatlantic Partners
Casdin Capital

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.